Dec 10, 2024
Category
Equity
AUM (Cr.)
8,688.65
Exit Load (%)
0.00
Min Inv Lumpsum
5,000
Expense Ratio
1.81
Sharpe Ratio
23.09
Beta Ratio
0.00
Fund Manager
Sailesh Raj Bhan
Inception Date
Jun 05, 2004
Risk Level
Very High
Investment Objective
The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies